Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 75, doi. 10.1007/s40265-016-0666-0
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2017 AND VI 77 AND IP 1
Results: 9
1
2
Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 29, doi. 10.1007/s40265-016-0670-4
- By:
- Publication type:
- Article
3
Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 67, doi. 10.1007/s40265-016-0672-2
- By:
- Publication type:
- Article
4
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 47, doi. 10.1007/s40265-016-0674-0
- By:
- Publication type:
- Article
5
Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 1, doi. 10.1007/s40265-016-0675-z
- By:
- Publication type:
- Article
6
Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph+ Acute Lymphoblastic Leukaemia.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 85, doi. 10.1007/s40265-016-0677-x
- By:
- Publication type:
- Article
7
Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion): A Review of Its Use in Haemophilia B.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 97, doi. 10.1007/s40265-016-0679-8
- By:
- Publication type:
- Article
8
Olaratumab: First Global Approval.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 107, doi. 10.1007/s40265-016-0680-2
- By:
- Publication type:
- Article
9
Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 17, doi. 10.1007/s40265-016-0665-1
- By:
- Publication type:
- Article